p63偼態娻偱傕梲惈偵側傞偙偲偑偁傞偺偱丆滸暯忋旂娻偺慻怐憸偑側偔丆p63偲TTF-1偺偄偢傟傕偑梲惈偱偁傞応崌偼懡偔偼態娻偱偁傞丏p40偼滸暯忋旂娻偱偼梲惈偵側傞偑態娻偱偼梲惈偵側傜偢丆滸暯忋旂娻偺儅乕僇乕偲偟偰偺摿堎搙偼p63傛傝傕崅偄丏
偟偐偟丆惗専/嵶朎恌昗杮偵偍偄偰丆宍懺憸偩偗偱態娻傗滸暯忋旂娻偲恌抐偱偒傞応崌傕偁傝丆忢偵柶塽愼怓峴偆昁梫偼側偄丏
adenocarcinoma (態娻)
態娻偲恌抐偱偒傞宍懺憸偑懚嵼偡傞応崌
惗専昗杮偺擲塼愼怓偵傛傝掅暘壔偺旕彫嵶朎娻偑擲塼傪擖傟傞庮釃嵶朎傪彮側偔偲傕俀屄桳偡傞応崌偼態娻偲恌抐偡傞丏
忋旂撪態娻偺恌抐偼丆揈弌昗杮慡懱傪娤嶡偡傞偙偲偵傛傝峴偊傞偨傔丆惗専昗杮偵lepidic僷僞乕儞偺傒傪擣傔偰傕丆忋旂撪態娻偱偼側偔丆adenocarcinoma with lepidic pattern偲偡傞丏
sqamous cell carcinoma乮滸暯忋旂娻)
滸暯忋旂娻偲恌抐偱偒傞宍懺憸偑懚嵼偡傞応崌
non-small cell lung carcinoma, favor adenocarcinoma (NSCLC, favor adenocarcinoma)乮旕彫嵶朎娻丆態娻偺媈偄乯
態娻偲恌抐偱偒傞宍懺憸偑懚嵼偟側偄偑丆TTF-1丆Napsin A偑梲惈傑偨偼擲塼愼怓偑梲惈偱丆p63, p40, CK5/6偑堿惈偱偁傞応崌
TTF-1偑梲惈偱偁傟偽丆滸暯忋旂娻偺儅乕僇乕偑梲惈偱偁偭偰傕丆NSCLC, favor adenocarcinoma偲恌抐偡傞丏
non-small cell lung carcinoma, favor squamous cell carcinoma (NSCLC, favor squamous cell carcinoma)乮旕彫嵶朎娻丆滸暯忋旂娻偺媈偄乯
滸暯忋旂娻偲恌抐偱偒傞宍懺憸偑懚嵼偟側偄偑丆TTF-1, Napsin A偑堿惈丆擲塼愼怓偑堿惈偱丆p63, p40, CK5/6偑梲惈偺応崌
non-small cell lung carcinoma, not otherwise specified (NSCLC, NOS)乮旕彫嵶朎娻丆NOS乯
TTF-1, Napsin A偑堿惈丆擲塼愼怓偑堿惈偱丆p63, p40, CK5/6傕堿惈偺応崌
態娻偺慻怐憸偲滸暯忋旂娻偺慻怐憸偑擣傔傜傟傞応崌偼丆NSCLC, NOS偲恌抐偟丆慻怐憸偑滸暯忋旂娻偲態娻偺暘壔傪帵偡偙偲傪僐儊儞僩偲偟偰婰嵹偡傞丏態滸暯忋旂娻偺壜擻惈傕偁傞偑丆態滸暯忋旂娻偼偦傟偧傟偺惉暘偑10%埲忋娷傑傟偰偄傞偙偲傪妋擣偡傞昁梫偑偁傞偨傔愗彍昗杮偱恌抐偟丆惗専/嵶朎恌偱偼恌抐偟側偄丏傑偨丆傑偨丆柶塽愼怓偱滸暯忋旂娻偺儅乕僇乕偲態娻偺儅乕僇乕偑偦傟偧傟堎側傞嵶朎偱梲惈偲側傞応崌偼丆摨偠庮釃嵶朎偵滸暯忋旂娻偺儅乕僇乕偲態娻偺儅乕僇乕偑摨帪偵梲惈偵側傞応崌傛傝傕丆態滸暯忋旂娻偺壜擻惈偑崅偄丏
possible large cell neuroendocrine carcinoma (戝嵶朎恄宱撪暘斿娻偺媈偄)
恄宱撪暘斿暘壔傪帵偡峔憿偑懚嵼偟丆柶塽愼怓偵傛傝CD56, chromogranin, synaptophysin側偳偑梲惈偱偁傞応崌
杮峞偵宖嵹偝傟偰偄傞尠旝嬀幨恀側偳偼丄屄恖偱巊梡偝傟傞応崌偼丄偛帺桼偵僟僂儞儘乕僪偟偰偄偨偩偄偨寢峔偱偡丅偨偩偟丄岞昞偝傟傞応崌傗儕儞僋傪偝傟傞応崌偼丄弌揟傪柧傜偐偵偟偰偔偩偝偄丅